Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor

NCT02151357 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped catheter occlusion events during the study drug infusion

Conditions

Cancer

Interventions

DRUG: DCBCI0901

Sponsor

Standard Chem. & Pharm. Co., Ltd.